OPRX OptimizeRx Corp
Services-Business Services, NEC · Nasdaq · SEC CIK 1448431 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-14.0%
TTM net income YoY14,655.9%
TTM EPS YoY2,500.0%
Revenue 3-yr CAGR14.5%
Net income 3-yr CAGR—
Margins
Gross margin75.3%
Operating margin12.3%
Net margin5.3%
FCF margin21.1%
EBITDA margin16.8%
Returns
ROE3.9%
ROA3.0%
ROIC (approx.)5.5%
Asset turnover0.57x
Leverage & solvency
Liabilities / assets17.4%
Debt / equity0.10x
Current ratio5.06x
Interest coverage3.12x
Cash quality & payout
Operating cash flow / net income3.98x
Accruals ratio-9.0%
Payout ratio—
Capex / revenue0.1%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $109.43M | $92.13M | $71.52M | $62.45M | $61.29M |
| Cost of revenue | $35.83M | $32.75M | $28.62M | $23.48M | $25.65M |
| Gross profit | $73.59M | $59.38M | $42.90M | $38.97M | $35.64M |
| R&D expense | $0 | $0 | — | — | — |
| SG&A expense | — | — | — | $33.49M | $27.70M |
| Operating income | $11.69M | -$13.71M | -$26.40M | -$12.29M | $361,100 |
| Interest expense | $5.29M | $6.16M | $1.45M | — | — |
| Pretax income | $6.95M | -$19.39M | -$25.16M | -$11.44M | $378,079 |
| Income tax | $1.82M | $725,000 | -$7.60M | — | — |
| Net income | $5.13M | -$20.11M | -$17.57M | -$11.44M | $378,079 |
| EBITDA | $16.02M | -$9.38M | -$24.00M | -$10.27M | $2.33M |
| EPS (basic) | 0.28 | -1.10 | -1.03 | -0.64 | 0.02 |
| EPS (diluted) | 0.27 | -1.10 | -1.03 | -0.64 | 0.02 |
| Weighted avg. shares (diluted) | 19.00M | 18.29M | 17.12M | 17.78M | 17.69M |
| Balance sheet | |||||
| Cash & equivalents | $23.36M | $13.38M | $13.85M | $18.21M | $84.68M |
| Short-term investments | $0 | $0 | — | $55.93M | — |
| Receivables | $37.75M | $38.21M | $36.25M | $22.16M | $24.80M |
| Current assets | $64.72M | $53.97M | $54.33M | $98.58M | $115.11M |
| PP&E, net | $106,000 | $150,000 | $149,000 | $137,448 | $143,818 |
| Goodwill | $70.87M | $70.87M | $78.36M | $22.67M | $14.74M |
| Intangibles | $40.80M | $45.52M | $6.18M | $13.02M | $10.65M |
| Total assets | $176.92M | $171.17M | $183.37M | $134.65M | $140.99M |
| Current liabilities | $21.26M | $18.65M | $17.88M | $8.40M | $9.37M |
| Short-term debt | $4.25M | $2.00M | $2.00M | — | — |
| Long-term debt | $21.42M | $30.82M | $34.23M | — | — |
| Total debt | $25.68M | $32.82M | $36.23M | — | — |
| Total liabilities | $48.62M | $54.17M | $56.82M | $8.54M | $9.61M |
| Shareholders' equity | $128.29M | $117.00M | $126.55M | $126.11M | $131.38M |
| Net debt | $2.31M | $19.44M | $22.38M | — | — |
| Shares outstanding | 18.76M | 18.45M | 18.16M | 18.29M | 17.86M |
| Cash flow statement | |||||
| Operating cash flow | $18.71M | $4.89M | -$7.24M | $10.65M | $726,039 |
| Capital expenditure | $58,000 | $112,000 | $87,000 | $81,005 | $100,322 |
| Free cash flow | $18.66M | $4.78M | -$7.33M | $10.57M | $625,717 |
| Investing cash flow | $68,000 | -$450,000 | -$25.34M | -$58.18M | -$485,999 |
| Financing cash flow | -$8.80M | -$4.91M | $28.22M | -$18.95M | $73.92M |
| Depreciation & amortization | $4.33M | $4.33M | $2.40M | $2.02M | $1.97M |
| Stock-based compensation | $6.96M | $11.47M | $13.72M | $15.75M | $5.49M |
| Share buybacks | — | — | $7.52M | $20.02M | — |
Free plan shows the latest 5 periods; Pro shows all 16 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.